Biotech Showcase is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Jim Healy
General Partner at Sofinnova Ventures


Jim joined Sofinnova in 2000 as a General Partner. He focuses on funding clinical stage private and publicly traded bio-pharmaceutical companies. He has financed or served on the board of ten companies which received drug approvals from either FDA or EMA, seventeen companies which completed initial public offerings, and eleven companies which were acquired as private or as public companies. Jim currently represents Sofinnova on the board of directors of Ascendis (ASND), Coherus (CHRS), Edge (EDGE), Natera (NTRA), Obseva (OBSV), Nucana (NCNA), Iterum (ITRM) and Y-mAbs (YMAB).

Agenda Sessions

  • Rare and orphan diseases: The biotech industry poised to make a dent in treatment and diagnosis - Hilton Union Square


Speakers at this event